C-reactive protein was elevated in the majority of myocarditis patients but it should still be used as an ancillary feature, rather than a specific diagnostic and prognostic biomarker, as it did not identify myocarditis patients with worse clinical features. This evidence concerns the gene CRP and myocarditis.